Antiparasitic Medications Flashcards
Major types of parasitic disease
- Protozoan (ie malaria, ameibiasis)
- Helminthe (ie ascariasis, enterobiasis)
Types of Treatment - Antiprotozoal Agents
- SUPPRESSIVE THERAPY: elimination of parasite responsible for acute symptoms
- CLINICAL CURE: removal of all parasites from blood
- RADICAL CURE: elimination of all parasite forms from the body
Antimalarial agents
- Chloroquine
- Primaquine
- Quinine (Cinchona alkaloid)
- Quinidine (Cinchona alkaloid)
- Mefloquine
- Pyrimethamine
- Atovaquone-proguanil (Malarone)
- Artemisinin and Derivatives
Antiprotozoal agents - Giardiasis
- Metronidazole
- Furazolidone
Antiprotozoal agents - Amebicidic
- Metronidazole
- Iodoquinol (diiodohydroxyquine)
- Paromomycin
Antihelminthic agents
- Mebendazole (Vermox)
- Ivermection
- Pyrantel pamoate (Antiminth)
- Thiabendazole
Chloroquine - Mechanism of Action
- Parasite digests HgB of host red cells
- HgB degradation product (ferriprotoporphyrin IX) is toxic to parasite membranes and essential enzymes
- Parasite protects itself from ferri IX with the activity of a heme polymerase
- CHLOROQUINE IS THOUGHT TO INHIBIT SEQUESTRATION OF HEME AND THIS HEME POLYMERASE
- Oxidative damage results
Chloroquine - Uses
Asexual and erythrocytic forms in susceptible parasites
Chloroquine - Pharmacokinetics
- Half-life: 4 days
- Allows for once weekly prophylaxis
Chloroquine - Resistance
Parasites actively transport chloroquine out of acidic digestive vacuole
Chloroquine - Adverse effects
- Headache, N/V, blurred vision, dizziness, fatigue, confusion
- RARE: depigmentation of hair, corneal opacities, hematological disorders, exacerbation of psoriasis, dose related retinopathy, hemolysis of G6PD deficient patients
Chloroquine - Contraindications
- Psoriasis
- Retinal disease
- Epilepsy
- Myasthenia gravis
Chloroquine - Indications
- Prevention and treatment of malaria
- Extraintestinal amebiasis (not FDA approved)
- Inflammatory disease (RA, SLE) (not FDA approved)
Primaquine - Mechanism of Action
Interferes with mitochondrial function
Primaquine - Uses
- Only agent available for treating exoerythrocytic hypnozoite forms of P. vivax and P. ovale in liver
- Some activity against asexual blood stages of P. vivax but this action is not sufficient for prophylaxis
- RADICAL CURE: P. vivax, P. ovale (prevent of relapse) - used after chloroquine in treatment or shortly before or just after chloroquine prophylaxis ends in persons with known exposure
Primaquine - Adverse effects
- Methhemoglobinemia
- Abdominal distress
- Hemolysis in G6PD deficient patients
Quinine (Cinchona alkaloid) - Mechanism of action
Similar to chloroquine
Quinine (Cichona alkaloid) - Uses
- Increased due to chloroquine resistance, quinine resistance now a problem
- Can be used for PARENTERAL THERAPY (not available in US) against chloroquine and multi-drug resistant P. falciparum (in other countries)
Quinine (Cichona alkaloid) - Adverse effects
- POOREST THERAPEUTIC TO TOXIC RATIO OF ALL ANTIMALARIAL AGENTS
- CINCHONISM: dose related and reversible
- Tinnitus, decreased hearing, headache, N/V, visual disturbances
- RARE: hypersensitivity, hypoglycemia, hemolysis in G6PD deficient patients
Quinidine (Cinchona alkaloid) - Mechanism of Action
Similar to chloroquine
Quinidine (Cinchona alkaloid) - Uses
- PARENTERAL therapy in chloroquine resistant P. falciparum (since quinine not available in US delays in therapy were occuring)
- Being replaced by ARTEMISININS
Quinidine - Adverse effects
- EKG changes
- Hypotension
Mefloquine - Mechanism of action
- Derived from quinine
Mefloquine - Uses
- Prophylaxis against drug resistant P. falciparum and P. vivax for travelers over extended periods into endemic areas
- Schizontocidal drug; no effect on exoerythrocytic stage
- Resistance to mefloquine is increasing in Thailand and West Africa
Mefloquine - Adverse effects
Causes vivid dreams